Quantum Genomics

Quantum Genomics

Pharmaceutical Manufacturing Paris, Fr 4 employees
Employees
4
Contacts
1
Emails
1

Quantum Genomics Overview

Headquarters
Paris, Fr
Phone Number
Available in AeroLeads
Industry
Pharmaceutical Manufacturing
Employees
4
Founded
2006
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Quantum Genomics

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.

Quantum Genomics Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage

Quantum Genomics Org Chart

Sample employees and titles
Name Title Contact
Bruno Besse Chief Medical Officer at Quantum
Email
Benoit Gueugnon Chief Financial Officer - Tilak
View

Employees by Management Level

Executive 2 profiles
Senior / Lead 1 profile
Individual contributor 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0
Executive 1 1 0

Compare Similar Companies to Quantum Genomics